Troy E. Wilson

2019

In 2019, Troy E. Wilson earned a total compensation of $3.2M as President and Chief Executive Officer at Kura Oncology, a 32% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$290,275
Option Awards$2,327,952
Salary$542,000
Other$75,990
Total$3,236,217

Wilson received $2.3M in option awards, accounting for 72% of the total pay in 2019.

Wilson also received $290.3K in non-equity incentive plan, $542K in salary and $76K in other compensation.

Rankings

In 2019, Troy E. Wilson's compensation ranked 3,767th out of 13,971 executives tracked by ExecPay. In other words, Wilson earned more than 73.0% of executives.

ClassificationRankingPercentile
All
3,767
out of 13,971
73rd
Division
Manufacturing
1,363
out of 5,701
76th
Major group
Chemicals And Allied Products
475
out of 2,200
78th
Industry group
Drugs
399
out of 1,886
79th
Industry
Pharmaceutical Preparations
301
out of 1,398
79th
Source: SEC filing on April 28, 2020.

Wilson's colleagues

We found five more compensation records of executives who worked with Troy E. Wilson at Kura Oncology in 2019.

2019

Kathleen Ford

Kura Oncology

Chief Operating Officer

2019

John Farnam

Kura Oncology

Chief Operating Officer

2019

Marc Grasso

Kura Oncology

Chief Financial Officer

2019

Antonio Gualberto

Kura Oncology

Chief Medical Officer

2019

James Basta

Kura Oncology

Chief Legal Officer

News

In-depth

You may also like